Atezolizumab-Induced Lambert-Eaton Myasthenic Syndrome in a Patient With Small-Cell Lung Cancer

The case of a 70-year-old man who developed Lambert-Eaton myasthenic syndrome (LEMS) while receiving   treatment for extensive-stage small-cell lung cancer (SCLC) is presented. He started receiving maintenance immunotherapy with atezolizumab following four cycles of combination therapy with  , carbo...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Curēus (Palo Alto, CA) CA), 2023-01, Vol.15 (1), p.e33557
Hauptverfasser:	Yamazoe, Masami, Hatakeyama, Taku, Furukawa, Kento, Kato, Koji, Horiuchi, Kazuhiro
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Blood Cancer therapies Chemotherapy Guillain-Barre syndrome Immunotherapy Lung cancer Monoclonal antibodies Patients Pleural effusion Steroids Targeted cancer therapy Thyroid gland
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!